In addition, Khushnuma et al. reported that aberrant promoter methylation of Parkin is a frequent incident, which causes its epigenetic inactivation in breast cancer via reducing the expression of Parkin protein.57 Parkin’s methylation and copy number loss have been linked with poor prognosis in breast cancer patients. This evidence concerns the gene PRKN and breast carcinoma.